Bank of America
KURA icon

Bank of America’s Kura Oncology KURA Stock Holding History

Bank of America’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10M Buy
1,230,131
+388,003
+46% +$3.33M ﹤0.01% 2961
2025
Q4 		$8.75M Buy
842,128
+269,953
+47% +$2.83M ﹤0.01% 2954
2025
Q3 		$5.06M Buy
572,175
+167,051
+41% +$1.19M ﹤0.01% 3996
2025
Q2 		$2.34M Sell
405,124
-72,479
-15% -$444K ﹤0.01% 4634
2025
Q1 		$3.15M Buy
477,603
+152,383
+47% +$1.19M ﹤0.01% 4264
2024
Q4 		$2.83M Sell
325,220
-25,195
-7% -$363K ﹤0.01% 4137
2024
Q3 		$6.85M Sell
350,415
-52,148
-13% -$1.06M ﹤0.01% 3442
2024
Q2 		$8.29M Sell
402,563
-78,059
-16% -$1.6M ﹤0.01% 3130
2024
Q1 		$10.3M Sell
480,622
-270,719
-36% -$5.26M ﹤0.01% 2959
2023
Q4 		$10.8M Buy
751,341
+580,885
+341% +$5.71M ﹤0.01% 2811
2023
Q3 		$1.55M Sell
170,456
-730,792
-81% -$7.42M ﹤0.01% 4487
2023
Q2 		$9.54M Buy
901,248
+395,044
+78% +$4.67M ﹤0.01% 2754
2023
Q1 		$6.19M Buy
506,204
+246,516
+95% +$3.08M ﹤0.01% 3328
2022
Q4 		$3.22M Buy
259,688
+239
+0.1% +$3.47K ﹤0.01% 3811
2022
Q3 		$3.54M Buy
259,449
+156,440
+152% +$2.41M ﹤0.01% 3702
2022
Q2 		$1.89M Sell
103,009
-145,548
-59% -$2.09M ﹤0.01% 4362
2022
Q1 		$4M Sell
248,557
-45,140
-15% -$652K ﹤0.01% 3870
2021
Q4 		$4.11M Buy
293,697
+212,618
+262% +$3.44M ﹤0.01% 3848
2021
Q3 		$1.52M Buy
81,079
+4,341
+6% +$81.8K ﹤0.01% 4688
2021
Q2 		$1.6M Sell
76,738
-5,677
-7% -$141K ﹤0.01% 4504
2021
Q1 		$2.33M Buy
82,415
+6,434
+8% +$204K ﹤0.01% 4131
2020
Q4 		$2.48M Sell
75,981
-3,546
-4% -$125K ﹤0.01% 3758
2020
Q3 		$2.44M Sell
79,527
-9,563
-11% -$211K ﹤0.01% 3509
2020
Q2 		$1.45M Buy
89,090
+6,517
+8% +$94K ﹤0.01% 3854
2020
Q1 		$821K Sell
82,573
-1,284
-2% -$14.7K ﹤0.01% 4146
2019
Q4 		$1.15M Sell
83,857
-15,275
-15% -$226K ﹤0.01% 4399
2019
Q3 		$1.5M Sell
99,132
-20,277
-17% -$361K ﹤0.01% 4269
2019
Q2 		$2.35M Buy
119,409
+6,661
+6% +$111K ﹤0.01% 3914
2019
Q1 		$1.87M Buy
112,748
+31,923
+39% +$492K ﹤0.01% 4044
2018
Q4 		$1.13M Sell
80,825
-13,090
-14% -$173K ﹤0.01% 4301
2018
Q3 		$1.64M Buy
93,915
+76,186
+430% +$1.46M ﹤0.01% 4139
2018
Q2 		$323K Buy
17,729
+13,578
+327% +$230K ﹤0.01% 5143
2018
Q1 		$78K Sell
4,151
-2,806
-40% -$54.6K ﹤0.01% 5854
2017
Q4 		$107K Buy
6,957
+6,058
+674% +$89.3K ﹤0.01% 5711
2017
Q3 		$13K Buy
+899
New +$8.44K ﹤0.01% 6448
2017
Q1 		– Sell
-1
Closed – – 7120
2016
Q4 		$0 Sell
1
-61
-98% -$327 ﹤0.01% 7180
2016
Q3 		$0 Sell
62
-248
-80% -$1.26K ﹤0.01% 7234
2016
Q2 		$1K Buy
+310
New +$964 ﹤0.01% 6992

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's KURA Position: Q1 2026 in Review

Bank of America increased its Kura Oncology (KURA) stake by 46% in Q1 2026, buying an estimated $3.33M and bringing the position to 1,230,131 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #2961.

Bank of America first reported a position in KURA in Q2 2016 and has held it in 38 quarters since. The position peaked at $10.8M in Q4 2023. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Bank of America held 1,230,131 shares of Kura Oncology worth $10M as of Q1 2026.
  • Bank of America bought 388,003 Kura Oncology shares in Q1 2026, an estimated $3.33M.
  • Kura Oncology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2961 holding.
  • Bank of America first reported a position in Kura Oncology in Q2 2016 and has held it in 38 quarters since.
  • Bank of America's Kura Oncology position peaked at $10.8M in Q4 2023.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.